Literature DB >> 11927591

Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.

Angus Chen1, Frida E Kleiman, James L Manley, Toru Ouchi, Zhen-Qiang Pan.   

Abstract

The RING finger of BRCA1 confers ubiquitin ligase activity that is markedly enhanced when complexed with another RING-containing protein, BARD1, and is required for the function of this tumor suppressor protein in protecting genomic integrity. Here, we report that co-expression of BRCA1-(1-639) and BARD1 in bacteria can assemble a potent ubiquitin ligase activity. Purified BRCA1-(1-639)*BARD1 stimulated the Ubc5c-mediated monoubiquitination of histone H2A/H2AX in vitro, suggesting a possible role for BRCA1*BARD1 in modifying chromatin structure. Moreover, the truncated BRCA1*BARD1 complex exhibited efficient autoubiquitination activity in vitro capable of assembling non-lysine 48-linked polyubiquitin chains on both BRCA1-(1-639) and BARD1. When co-expressed in cells by transient transfection, the recombinant BRCA1-(1-300).BARD1 complex was found to be associated with polyubiquitin chains, suggesting that BRCA1-(1-300)*BARD1 was ubiquitinated in vivo as well. These results raise the possibility that BRCA1*BARD1 acts to assemble non-lysine 48-linked polyubiquitin chains that may serve as part of a signaling platform required for coordinating DNA repair-related events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927591     DOI: 10.1074/jbc.M201252200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  The RAG1 N-terminal domain is an E3 ubiquitin ligase.

Authors:  Vyacheslav Yurchenko; Zhu Xue; Moshe Sadofsky
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

2.  Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.

Authors:  Donna L Mallery; Cassandra J Vandenberg; Kevin Hiom
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  Control of biochemical reactions through supramolecular RING domain self-assembly.

Authors:  Alex Kentsis; Ronald E Gordon; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

4.  Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage.

Authors:  Jeanho Yun; Wen-Hwa Lee
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

5.  Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.

Authors:  Peter S Brzovic; Jennifer R Keeffe; Hiroyuki Nishikawa; Keiko Miyamoto; David Fox; Mamoru Fukuda; Tomohiko Ohta; Rachel Klevit
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

6.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

Authors:  Lea M Starita; Yuka Machida; Satish Sankaran; Joshua E Elias; Karen Griffin; Brian P Schlegel; Steven P Gygi; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 7.  Pericentric and centromeric transcription: a perfect balance required.

Authors:  Laura E Hall; Sarah E Mitchell; Rachel J O'Neill
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

8.  The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.

Authors:  Foon Wu-Baer; Thomas Ludwig; Richard Baer
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

9.  Quantitative proteomic identification of the BRCA1 ubiquitination substrates.

Authors:  Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

10.  Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.

Authors:  Ellen E McCarthy; Julide T Celebi; Richard Baer; Thomas Ludwig
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.